FDA label
What is ethosuximide used for?
The FDA-approved uses of ethosuximide, quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “Ethosuximide is indicated for the control of absence (petit mal) epilepsy.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted ethosuximide?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Ethosuximide, solution
Indications and Usage, quoted from the label by Mylan Pharmaceuticals Inc. (ANDA080258). Cross-references to other label sections are left out.
Ethosuximide is indicated for the control of absence (petit mal) epilepsy.
Source: DailyMed label, set id 19c924c2-f558-4c78-9277-2d7e0df2f505, version 17, effective July 24, 2026. NDC 59762-2350, one of 5 listings for this product.
Questions
What is ethosuximide used for?
The FDA label says: “Ethosuximide is indicated for the control of absence (petit mal) epilepsy.”
What drug class is ethosuximide?
FDA lists ethosuximide in the Anti-epileptic Agent established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.